| Soluble Guanylate Cyclase Stimulators and Activators: Where are We and Where to Go? S Xiao, Q Li, L Hu, Z Yu, J Yang, Q Chang, Z Chen, G Hu Mini Reviews in Medicinal Chemistry 19 (18), 1544-1557, 2019 | 32 | 2019 |
| Discovery of Novel Pyrazolo [3, 4-b] pyridine Derivatives with Dual Activities of Vascular Remodeling Inhibition and Vasodilation for the Treatment of Pulmonary Arterial … L Hu, L Li, Q Chang, S Fu, J Qin, Z Chen, X Li, Q Liu, G Hu, Q Li Journal of Medicinal Chemistry, 2020 | 22 | 2020 |
| Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents Q Chang, J Long, L Hu, Z Chen, Q Li, G Hu Bioorganic & Medicinal Chemistry, 115404, 2020 | 7 | 2020 |
| Soluble Guanylate Cyclase: A New Therapeutic Target for Fibrotic Diseases L Hu, Z Wang, R Yi, H Yi, S Xiao, Z Chen, G Hu, Q Li Current Medicinal Chemistry 24 (29), 3203-3215, 2017 | 6 | 2017 |
| New Insights Into Heat Shock Protein 90 in the Pathogenesis of Pulmonary Arterial Hypertension L Hu, R Zhao, Q Liu, Q Li Frontiers in Physiology 11, 2020 | 4 | 2020 |
| Advances in soluble guanylate cyclase stimulator L HU, R YI, Q LI Journal of China Pharmaceutical University 47, 531-6, 2016 | 1 | 2016 |
| Recent advances in research of AMPK activators as anticancer agents X JIANG, L HU, R YI, Q LI Chinese Journal of New Drugs 2015 (24), 11, 2015 | | 2015 |
